The Wilms' tumor suppressor WT1: Approaches to gene function

Kidney International

Volumn 53, Issue 6, 1998, Pages 1512-1518

  Menke, Aswin ^b   Mcinnes, Lesley ^b   Hastie, Nicholas D ^b   Schedl, Andreas ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b NONE

Author keywords

Cancer; Childhood tumor; Chromosomes; Development

Indexed keywords

CARCINOGENESIS; CHILDHOOD CANCER; CONFERENCE PAPER; GENE EXPRESSION; GENE FUNCTION; NEPHROBLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

EID: 0031779074     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00935.x     Document Type: Conference Paper

References (63)

1. COLES HSR, BURNE JF, RAFF MC: Large scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development 118:777-784, 1993
2. TON CC, HIRVONEN H, MIWA H, WEIL MM, MONAGHAN P, JOPRDAN T, VAN HEYNINGEN V, HASTIE ND, MEIJERS-HEIJBOER H, DRECHSLER M, ROYER-POKORA B, COLLINS F, SWAROOP A, STRONG LC, SAUNDERS GF: Positional cloning and characterisation of a paired box- and homeobox-containing gene from the aniridia region. Cell 67:1059-1074, 1991
3. KENT J, LEE M, SCHEDL A, BOYLE S, FANTES J, POWELL M, RUSHMORE N, MORGAN P, ABBOTT C, VAN HEYNINGEN V, BICKMORE WA: Identification of genes removed by the small eye Harwell deletion. Genomics 42:260-267, 1997
4. CALL KM, GLASER T, ITO CY, BUCKLER AJ, PELLETIER J, HABER DA, ROSE EA, KRAL A, YEGER H, LEWIS WH, JONES C, HOUSMAN DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509-520, 1990
5. GESSLER M, KONIG A, BRUNS GA: The genomic organization and expression of the WT1 gene. Genomics 12:807-813, 1992
6. HABER DA, SOHN RL, BUCKLER AJ, PELLETIER J, CALL KM, HOUSMAN DE: Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88:9618-9622, 1991
7. TADOKORO K, OKI N, FUJII H, OHSHIMA A, INOUE T, YAMADA M: Genomic organisation of the human WT1 gene. Jpn J Cancer Res 83:1198-1203, 1992
8. MORRIS JF, MADDEN SL, TOURNAY OE, COOK DM, SUKHATME VP, RAUSCHER FJ: Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6:2339-2348, 1991
9. BRUENING W, PELLETIER J: A non-AUG translation initiation event generates novel WT1 isoforms. J Biol Chem 271:8646-8654, 1996
10. SCHARNHORST V, KRANENBURG O, VAN DER EB AJ, JOCHEMSEN AG: Differential regulation of the Wilms' Tumor gene, WT1 during differentiation of embryonal carcinoma and embryonic stem cells. Cell Growth Differ 8:133-143, 1997
11. SHARMA PM, BOWMAN M, MADDEN SL, RAUSCHER FJ III, SUKUMAR S: RNA editing in the Wilms' tumor susceptibility gene, WT1. Gene Develop 8:720-731, 1994
12. RAUSCHER FJ, MORRIS JF, TOURNAY OE, COOK DM, CURRAN T: Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259-1262, 1990
13. NAKAGAMA H, HEINRICH G, PELLETIER J, HOUSMAN DE: Sequence and structural requirements for high-affinity DNA-binding by the WT1 gene product. Mol Cell Biol 15:1489-1498, 1995
14. HAMILTON TB, BARILLA KC, ROMANIUK PJ: High affinity binding sites for the Wilms' tumour suppressor protein WT1. Nucl Acids Res 23:277-284, 1995
15. WANG Z-Y, QIU Q-Q, ENGER KT, DEUEL T: A second transcriptionally active DNA-binding site for Wilms tumor gene product, WT1. Proc Natl Acad Sci USA 90:8896-8900, 1993
16. MADDEN SL, COOK DM, MORRIS JF, GASHLER A, SUKHATME VP, RAUSCHER FJ III: Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science 253:1550-1553, 1991
17. BICKMORE WA, OGHENE K, LITTLE MH, SEAWRIGHT A, VAN HEYNINGEN V, HASTIE ND: Modulation of DNA binding specificity by alternative splicing of the Wilms tumor WT1 gene transcript. Science 257:235-237, 1992
18. DRUMMOND IA, RUPPRECHT HD, ROHWER-NUTTER P, LOPEZ-GUISA JM, MADDEN SL, RAUSCHER FJ III, SUKHATME VP: DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol 14:3800-3809, 1994
19. WANG Z, QIU Q, HUANG J, GURRIERI M, DEUEL TF: Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, WT1, have altered DNA binding specificity and regulate transcription in different ways. Oncogene 10:415-422, 1995
20. RUPPRECHT HD, DRUMMOND IA, MADDEN SL, RAUSCHER FJ III, SUKHATME VP: The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198-6206, 1994
21. RYAN G, STEELE-PERKINS V, MORRIS JF, RAUSCHER FJ III, DRESSLER GR: Repression of Pax-2 by WT1 during normal kidney development. Development 121:867-875, 1995
22. MADDEN SL, COOK DM, RAUSCHER FJ III: A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein. Oncogene 8:1713-1720, 1993
23. MAHESWARAN S, PARK S, BERNARD A, MORRIS JF, RAUSCHER FJ, HILL DE, HABER DA: Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90:5100-5104, 1993
24. ENGLERT C, HOU X, MAHESWARAN S, BENNETT P, NGWU C, RE GG, GARVIN AJ, ROSNER MR, HABER DA: WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662-4675, 1995b
25. REDDY JC, HOSONO S, LICHT JD: The transcriptional effect of WT1 is modulated by choice of expression vector. J Biol Chem 270:29976-29982, 1995b
26. LARSSON SH, CHARLIEU JP, MIYAGAWA K, ENGELKAMP D, RASSOULZADEGAN M, ROSS A, CUZIN F, VAN HEYNINGEN V, HASTIE ND: Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391-401, 1995
27. KENNEDY D, RAMSDALE T, MATTICK J, LITTLE M: An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling. Nature Genet 12:329-332, 1996
28. ENGLERT C, VIDAL M, MAHESWARAN S, GE Y, EZZELL R, ISSELBACHER KJ, HABER DA: Truncated WT1 mutants alter the subnuclear localization of the wild-type protein. Proc Natl Acad Sci USA 92: 11960-11964, 1995a
29. MENKE AL, RITECO N, VAN HAM RCA, DE BRUYNE C, RAUSCHER FJ III, VAN DER EB AJ, JOCHEMSEN AG: Wilms' Tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogene 12:537-546, 1996
30. LUO X-N, REDDY JC, YEYATI PL, IDRIS AH, HOSONO S, HABER DA, LICHT JD, ATWEH GF: The tumor suppressor gene WT1 inhibits ras-mediated transformation. Oncogene 11:743-750, 1995
31. MENKE AL, SHVARTS A, RITECO N, VAN HAM RCA, VAN DER EB AJ, JOCHEMSEN AG: Wilms' tumor 1-Kts isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor. Cancer Res 57:1353-1363, 1997
32. ALGAR EM, KHROMYKH T, SMITH SI, BLACKBURN DM, BRYSON GJ, SMITH PJA: WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12:1005-1014, 1996
33. JOHNSTONE RW, SEE RH, SELLS SF, WANG J, MUTHUKKUMAR S, ENGLERT C, HABER DA, LICHT JD, SUGRUE SP, ROBERTS T, RANGNEKAR VM, SHI Y: A novel reppressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1. Mol Cell Biol 16:6945-6956, 1996
34. WANG Z-Y, QIU Q-Q, SEUFERT W, TAGUCHI T, TESTA JR, WHITMORE SA, CALLEN DF, WELSH D, SHENK T, DEUEL TF: Molecular cloning of the cDNA and chromosome localization of the gene for human uhiquitin-conjugating enzyme 9. J Biol Chem 271:24811-24816, 1996
35. KUDOH T, ISHIDATE T, MORIYAMA M, TOYOSHIMA K, AKIYAMA T: G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/cdk complexes. Proc Natl Acad Sci USA 92:4517-4521, 1995
36. KREIDBERG JA, SARIOLA H, LORING JM, MAEDA M, PELLETIER J, HOUSMAN D, JAENISCH R: WT-1 is required for early kidney development. Cell 74:679-691, 1993
37. SHARMA PM, YANG X, BOWMAN M, ROBERTS V, SUKUMAR S: Molecular cloning of rat Wilms' tumor complementary DNA and study of of messenger RNA expression in the urogenital system and the brain. Cancer Res 52:6407-6412, 1992
38. BRENNER B, WILDHARDT G, SCHNEIDER S, ROYER-POKORA B: RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors. Oncogene 7:1431-1433, 1992
39. WALKER C, RUTTEN F, YUAN X, PASS H, MEW DM, EVERITT J: Wilms' Tumor suppressor gene expression in rat and human mesothelioma. Canc Res 54:3101-3106, 1994
40. FANTES JA, OGHENE K, BOYLE S, DANES S, FLETCHER JM, BRUFORD EA, WILLIAMSON K, SEAWRIGHT A, SCHEDL A, HANSON I, ZEHETNER G, BHOGAL R, LEHRACH H, GREGORY S, WILLIAMS J, LITTLE P, SELLAR GC, HOOVERS J, MANNENS M, WEISSENBACH J, JUNIEN C, VAN HEYNINGEN V, BICKMORE WA: A high-resolution integrated physical, cytogenetic and genetic map of human chromosome 11: Distal p13 to proximal p15.1. Genomics 25:447-461, 1995
41. HASTIE, ND: The genetics of Wilms' tumor-A case of disrupted development. (Review) Annu Rev Genet 28:523-558, 1994
42. KISTNER A, GOSSEN M, ZIMMERMANN F, JERECIC J, ULLMER C, LUBBERT H, BUJARD H: Doxycycline-mediated quantitative and tissue-specitic control of gene expresion in transgenic mice. Proc Natl Acad Sci USA 93:10933-10938, 1996
43. HOFMANN W, ROYER H-D, DRECHSLER M, SCHNEIDER S, ROYER-POKORA B: Characterization of the transcriptional regulatory region of the human WT1 gene. Oncogene 8:3123-3132, 1993
44. MALIK KTA, POIRIER V, IVINS SM, BROWN KW: Autoregulation of the human WT1 gene promoter. FEBS Lett 349:75-78, 1994
45. HEWITT SM, FRAIZER GC, WU YJ, RAUSCHER FJ III, SAUNDERS GF: Differential function of the Wilms' tumor gene WT1 splice isoforms in transcriptional regulation. J Biol Chem 271:8588-8592, 1996
46. NICHOLS KE, RE GG, YAN YX, GARVIN AJ, HABER DA: WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells. Cancer Res 55:4540-4543, 1995
47. WERNER H, RAUSCHER FJ III, SUKHATME VP, DRUMMOND IA, ROBERTS CT JR, LEROITH D: Transcriptional represion of the insulin-like growth factor 1 receptor (IGF-I-R) gene by the tumor suppresor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 269:12577-12582, 1994
48. WERNER H, RE GG, DRUMMOND IA, SUKHATME VP, RAUSCHER FJ III, SENS DA, GARVIN AJ, LEROITH D, ROBERTS CT JR: Increased expression of the insulin-like growth factor 1 receptor gene, IGFIR, in Wilms tumor is correlated with modulation of IGFIR promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci USA 90:5828-5832, 1993
49. WANG, ZY, MADDEN SL, DEUEL TF, RAUSCHER FJ III: The Wilms' Tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999-22002, 1992
50. WANG Z-Y, QIU Q-O, DEUEL TF: The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J Biol Chem 268:9172-91715, 1993
51. WANG Z, QIU Q, GURRIERI M, HUANG, J, DEUEL TF: WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene 10:1243-1247, 1995b
52. GASHLER AL, BONTHRON DT, MADDEN SL, RAUSCHER FJ III, COLLINS T, SUKHATME VP: Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms' Tumor suppressor WT1. Proc Natl Acad Sci USA 89:10984-10988, 1992
53. HARRINGTON MA, KONICEK H, SONG A, XIA X-L, FREDERICKS WJ, RAUSCHER FJ III: Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J Biol Chem 268:21271-21275, 1993
54. DEY BR, SUKHATME VP, ROBERTS AB, SPORN MB, RAUSCHER FJ III, KIM S-J: Repression of the transforming growth factor-b1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol 8:595-602, 1994
55. MARTINERIE C, CHEVALIER G, RAUSCHER FJ III, PERBAL B: Regulation of nov by WT1: A potential role for nov in nephrogenesis. Oncogene 12:1479-1492, 1996
56. GOODYER P, DEHBI M, TORBAN E, BRUENING W, PELLETIER J: Repression of the retinoic acid receptor-a gene by the Wilms' tumor suppressor gene product, WT1. Oncogene 10:1125-1129, 1995
57. HSU SY, KUBO M, CHUN S-Y, HALUSKA FG, HOUSMAN DE, HSUEH AJW: Wilms' tumor protein WT1 as an ovarian transcription factor: Decreases in expression during follicle development and repression of inhihin-a gene promoter. Mol Endocrinol 9:1356-1366, 1995
58. MCCANN S, SULLIVAN J, GUERRA J, ARCINAS M, BONER LM: Repression of the c-myb gene by WT1 protein in T and B cell lines. J Biol Chem 270:23785-23789, 1995
59. MOSHIER JA, SKUNCA M, WU W, BOPPANA SM, RAUSCHER FJ III, DOSESCU J: Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Nucl Acids Res 24:1144-1157, 1996
60. 1-2 protooncogene transcription. J Biol Chem 271:30760-30764, 1996
61. HEWITT SM, HAMADA S, MCDONNELI TJ, RAUSCHER FJ III, SAUNDERS GF: Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' Tumor suppressor gene WT1. Cancer Res 55:5386-5389, 1995
62. COOK DM, HINKES MT, BERNFIELD M, RAUSCHER FJ III: Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene 13:1789-1799, 1996
63. ADACHI Y, MATSUBARA S, PEDRAZA C, OZAWA M, TSUTSUI J-I, TAKAMATSU H, NOGUCHI H, AKIYAMA T, MURAMATSU T: Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1). Oncogene 13:2197-2203, 1996